Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Family Medicine
Anemia Clinical Trials
A listing of Anemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Anniston : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Birmingham : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Birmingham : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Birmingham : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Huntsville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Mobile : University of South Alabama
Effects of HQK-1001 in Patients With Sickle Cell Disease
Mobile : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Montgomery : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Arizona
Goodyear : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Peoria : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Phoenix : Phoenix Children's Hospital - Ctr for Cancer and Blood Disorders
Effects of HQK-1001 in Patients With Sickle Cell Disease
Phoenix : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Phoenix : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Phoeniz : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Tempe : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Tempe : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Tempe :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Tempe : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Tempe : Southwestern Kidney Institute Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Tucson : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Arkansas
Fayetteville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Hot Springs : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Jonesboro : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Little Rock : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pine Bluff : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
California
Alhambra : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Anaheim : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Anaheim : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Azusa : North America Research Institute
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Azusa : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
View More »
Azusa : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Bell Gardens : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Beverly Hills : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Cerritos : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Chino : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Chula Vista : Investigational Site
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
Chula Vista : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
East Los Angeles : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Fountain Valley : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Fresno : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fullerton : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Garden Grove : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Granada Hills : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Granada Hills : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Huntington Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Inglewood : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
La Jolla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
La Mesa : California Institute of Renal Research
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
La Mesa :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
La Mesa : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
La Verne : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Laguna Hills : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Laguna Hills : Alliance Research Centers Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Lakewood : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lancaster : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lomita : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Los Angeles : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Los Angeles : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Los Angeles : Academic Medical Research Institute
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Los Angeles : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Los Angeles : Childrens Hospital Los Angeles
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Los Angeles : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Los Angeles : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Los Angeles : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Los Angeles : Academic Medical Research Institute Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Lynwood : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Lynwood : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Lynwood : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lynwood : Kidney Research Center Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Merced : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mission Hills : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Monterey Park : Monterery Park Dialysis Center
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Northridge : Investigational Site
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
Northridge : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Northridge :
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Northridge : Valley Renal Medical Group Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Oakland : Children's Hospital and Research Center - Oakland
Effects of HQK-1001 in Patients With Sickle Cell Disease
Orange : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Orange : Nephrology Specialist Medical Group
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Orange : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Oxnard : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Palm Springs : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Paramount : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Redondo Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Riverside : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Riverside : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Riverside : Investigational Site
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
Riverside : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Sacramento : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Sacramento, : Capital Nephrology Medical Group Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
San Diego : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
San Dimas : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
San Dimas : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Stanford : Stanford University School of Medicine
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
Stanford : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Tarzana : Lawrence May, MD, Inc.
Red Blood Cell Precursor Formulation to Determine Increased Production
Torrance : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Vallejo : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
West Hills : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Whittier : American Institute of Research
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Whittier : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Whittier : American Institute of Research Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Yuba City : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Yuba City : Investigational Site
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
Yuba City : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Yuba City :
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Colorado
Denver : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Denver :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Denver : Rocky Mountain Cancer Centers
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Westminster : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Connecticut
Bridgeport : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Middlebury : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
New Haven : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
North Haven : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Orange : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
View More »
Southington : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Waterbury : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
District of Columbia
Washington : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Washington : Children's National Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Washington : Howard University Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Washington : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Florida
Boynton Beach : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Boynton Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Coral Springs : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Coral Springs : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Coral Springs : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Daytona Beach : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Daytona Beach : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Daytona Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Edgewater : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Holiday : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Hollywood : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Hudson : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Jacksonville : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Jacksonville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Jacksonville Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lauderdale Lakes : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lecanto : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Melbourne : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Miami : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Miami : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Miami : GSK Investigational Site
Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment
Miami :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Miami : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Miami : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Miami Beach : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
New Port Richey : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
New Port Richey : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Ocala : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Ocala :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Orange City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Orlando : GSK Investigational Site
Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment
Orlando : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Pembroke Pines : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Pembroke Pines : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Pembroke Pines : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Port Charlotte : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Port Charlotte : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Summerfield : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Tampa : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Tampa : H. Lee Moffitt Cancer Center
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Titusville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Georgia
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Atlanta : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Augusta : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Augusta : Georgia Health Sciences University
Effects of HQK-1001 in Patients With Sickle Cell Disease
Augusta : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Canton : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Macon : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Macon : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Newnan : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Savannah : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Stockbridge : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Thomasville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Hawaii
Honolulu : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Idaho
Meridian : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Meridian :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Meridian : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Illinois
Centralia : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Chicago : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Chicago : University of Illinois at Chicago
Effects of HQK-1001 in Patients With Sickle Cell Disease
Chicago : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Evanston : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
View More »
Evanston : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Galesburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Gurnee : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Mount Vernon : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Peoria : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Quincy : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Skokie : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Indiana
Iowa
Ames : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Iowa City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Iowa City : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Sioux City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kansas
Hutchinson : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kansas City : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Wichita : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Wichita : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Kentucky
Hazard : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lexington : University of Kentucky Medical Center
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Lexington : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Louisville : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Mt Sterling : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Paducah : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Louisiana
Alexandria : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Baton Rouge : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Lafayette : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lafayette : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Marrero : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Metairie : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Natchitoches : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
New Orleans : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Ruston : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Shreveport : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Shreveport : LSU Health Sciences Center
Effects of HQK-1001 in Patients With Sickle Cell Disease
Shreveport : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Maine
Rockport : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Maryland
Baltimore : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Baltimore : GSK Investigational Site
Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers
Bethesda : US National Institutes of Health - National Heart, Lung, and Blood Institute
A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
Bethesda : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bethesda :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
View More »
Bethesda : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Cumberland : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Frederick : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Oxon Hills : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Towson : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Massachusetts
Boston : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Boston : Tufts Medical Center
Effects of HQK-1001 in Patients With Sickle Cell Disease
Boston : Brigham and Women's Hospital
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Boston : Dana-Farber Cancer Institute
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Boston : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
View More »
Cambridge : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lexington : AMAG Pharmaceuticals, Inc.
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Lexington : AMAG Pharmaceuticals, Inc.
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Dialysis Dependent Chronic Kidney Disease
Lexington : AMAG Pharmaceuticals, Inc.
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-Dependent Chronic Kidney Disease
Plymouth : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Springfield : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Michigan
Detroit : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Detroit :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Detroit : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Detroit :
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Flint : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Grand Rapids : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Grand Rapids : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Kalamazoo : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Midland : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Pontiac : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Southfield : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Southgate : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Minnesota
Minneapolis : GSK Investigational Site
Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment
Mississippi
Columbus : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Gulfport : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Jackson : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tupelo : Fresenius Medical Care North America
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Missouri
Jefferson City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kansas City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kansas City : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Kansas City : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Kansas City : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
View More »
St. Louis : Washington University School of Medicine
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
St.Louis : Chromalloy American Kidney Center
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Montana
Great Falls : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kalispell : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Nebraska
Grand Island : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lincoln : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
North Platte : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Omaha : Creighton University Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Nevada
Henderson : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Henderson : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Las Vegas : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Las Vegas : Kidney Specialists of Southern Nevada Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
North Las Vegas : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
New Hampshire
Lebanon : (851) Dartmouth Hitchcock Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Manchester : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
New Jersey
Plainsboro : Women's Health Research Center, LLC
A Phase 2a Proof of Concept Study to Evaluate the Safety and Efficacy of Elagolix in Pre-Menopausal Women with Heavy Uterine Bleeding and Uterine Fibroids
View More »
Bayonne : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Livingston : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Livingston : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Sparta : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Teaneck : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Toms River : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
The Testosterone Trial - Can testosterone treatment improve unwanted effects of aging in older men?
Jamaica : Biomedical Research Alliance of New York
Anemia - cancer
Jamaica : Biomedical Research Alliance of New York
Anemia- cancer
New Hyde Park : Biomedical Research Alliance of New York
Diamond Blackfan Anemia - Adults
New York : The Rockefeller University Hospital
Entrance into the International Fanconi Anemia Registry (IFAR)
View More »
Bronx : The Children's Hospital at Montefiore Medical Center
Effects of HQK-1001 in Patients With Sickle Cell Disease
Bronx : Montefiore Medical Center
Intravenous Gammaglobulin for Sickle Cell Pain Crises
Bronx : Montefiore Medical Center-Department of Medical Oncology
Lenalidomide and Eltrombopag in Low and Intermediate Risk MDS
Bronx : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Brooklyn : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Brooklyn : New York Methodist Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Buffalo : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Flushing : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Glens Falls : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Goshen : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Great Neck :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Great Neck : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Latham : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mineola :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Mineola : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
New York : Memorial Sloan Kettering Cancer Center
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
New York : Mount Sinai School of Medicine
Intravenous Gammaglobulin for Sickle Cell Pain Crises
New York : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Nyack : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Orchard Park : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Rosedale : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Staten Island : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Valhalla : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Yonkers : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
North Carolina
Wilmington : Trial Management Associates
Iron Deficiency Anemia - Have you been diagnosed with anemia or have low iron? Do you feel run down or tired all the time?
View More »
Asheboro : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Asheville : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Asheville :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Asheville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Chapel Hill : University of North Carolina at Chapel Hill
Effects of HQK-1001 in Patients With Sickle Cell Disease
Charlotte : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Charlotte : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Concord : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Durham : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Goldsboro : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Greenville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
High Point : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Huntersville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kinston : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mooresville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Statesville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Washington : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Wilmington : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Wilmington :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Wilmington : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Winston-Salem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Winston-Salem : Brookview Hills Research Associates, LLC
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Winston-Salem : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
North Dakota
Bismarck : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fargo : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Grand Forks : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Ohio
Columbus : Columbus Center for Women's Health Research
Uterine Fibroids and Anemia
View More »
Akron : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Cincinnati : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Cleveland : MetroHealth Medical Systems
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Cleveland : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Columbus : James Cancer Hospital
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Columbus : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Columbus : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Marion : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Middletown : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Oklahoma
Oklahoma City : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Oregon
Portland : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Portland : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Portland : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Roseburg : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Pennsylvania
Beaver : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Bethlehem : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Bethlehem : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bethlehem : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Bethlehem : Northeast Clinical Research Centers, Inc. Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
View More »
Duncansville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Gettysburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Norristown : Luitpold Pharmaceuticals, Inc.
Intravenous Ferric Carboxymaltose (FCM) Versus IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
Philadelphia : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Philadelphia : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Pittsburgh : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Uniontown : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Upland : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Willow Grove : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Wynnewood : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
South Carolina
Aiken : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Charleston : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Columbia : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Greenville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Hilton Head Island : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Orangeburg : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Orangeburg : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Sumter : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
South Dakota
Aberdeen : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sioux Falls : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Watertown : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tennessee
Bristol : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Dyersburg : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Dyersburg : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Jackson : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Jackson : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Kingsport : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Knoxville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Knoxville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Memphis : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Nashville : Nephrology Associates, PC
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Texas
Abilene : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Amarillo : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Amarillo : Texas Oncology
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Arlington : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Arlington : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
View More »
Arlington : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Austin : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Austin : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Beaumont : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bryan : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Corpus Chisti : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Corpus Christi : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Corsicana : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Corsicana : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Dallas : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fort Worth : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Fredericksburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Frisco : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Garland : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Greenville : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Greenville : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Greenville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Harlingen : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Houston : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Houston : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Houston : Diagnostic Clinic of Houston
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Houston : Innovative Renal Care
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Houston : (855) University of Texas, MD Anderson Cancer Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Houston : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Houston :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Houston : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Houston : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Houston : Nephrology, P.A. Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Lufkin : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
McAllen : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
McAllen : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Mesquite : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Paris : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Round Rock : Texas Oncology
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
San Antonio : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
San Antonio : GSK Investigational Site
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
San Antonio : San Antonio Kidney Disease
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
San Antonio : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
San Antonio :
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
San Antonio : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
San Antonio : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
San Antonio : Renal Associates, PA Updated
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Tyler : Fresenius Medical Care
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Tyler : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tyler : Texas Oncology
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Utah
Ogden : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Vermont
Burlington : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
White River Junction : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Virginia
Alexandria : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Charlottesville : University of Virginia - Nephrology Clinical Research Center
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Charlottesville : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Chesapeake : Research Site
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Chesapeake : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
View More »
Fairfax : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fairfax : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Hampton : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Manassas : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Mechanicsville : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Newport News : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Norfolk : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Norfolk : Virginia Oncology Associates
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Norfolk : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Portsmouth : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Richmond : Virginia Commonwealth Univeristy - Center on Health Disparities
Effects of HQK-1001 in Patients With Sickle Cell Disease
Richmond : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Washington
Bremerton : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Silverdale : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Silverdale : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Spokane : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tacoma : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2787106 in Cancer and Anemia
Vancouver : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
West Virginia
Bluefield : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Wisconsin
Green Bay : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Janesville : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Milwaukee : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Argentina
Berazategui : Centro Oncologico de Investigaciones Buenos Aires
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
Buenos Aires : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Buenos Aires : Centro de Medicina Integral e Investigación Clínica
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
Ciudad Autónoma de Buenos Aires : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lanus Este : Hospital Zonal Especializado en Oncología de Lanus
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
View More »
Quilmes : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Rosario : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
San Miguel de Tucuman : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Santa Fe : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Australia
Woolloongabba : (004) Princess Alexandra Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Austria
Graz : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Graz : University Hospital
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Innsbruck : (151) Medizinische Universitat Innsbruck
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Innsbruck : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Linz : (153) Krankenhaus der Elisabethinen Linz, Interne Abteilung
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
View More »
Salzburg : (154) Universitätsklinik für Innere Medizin Salzburg
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
St Poelten : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Vöcklabruck : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Vienna : AKH Vienna
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Vienna : Wilhelminenspital
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Wels : (155) Klinikum Wels-Grieskirchen GmbH
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Wels : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Wien : (152) Wiener Gebietskrankenkasse-Hanusch-Krankenhaus
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Wien : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Belgium
Aalst : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bonheiden : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brasschaat : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brugge : (203) Algemeen Ziekenhuis Sint-Jan
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Brugge : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Brussels : (206) Cliniques Universitaires Saint Luc
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Charleroi : (205) Grand Hôpital de Charleroi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Eupen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gilly : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ieper : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Liège : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Libramont : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Liege : (201) Centre Hospitalier Universitaire Sart Tilman Liège
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Mechelen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Namur : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Oostende : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ottignies : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sint-Niklaas : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Verviers : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Yvoir : (207) Cliniques Universitaires UCL de Mont-Godinne
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Brazil
Belo Horizonte : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Brasilia : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Campo Grande : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Curitba : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fortaleza : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Ijui : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
ItajaÃ- : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Londrina : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Passo Fundo : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pelotas : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Porto Alegre : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Ribeirao Preto : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Rio de Janeiro : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
São Paulo : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Salvador : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Santo Andre : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sao Jose dos Campos : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bulgaria
Plovdiv : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Plovdiv : University Hospital
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Sofia : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sofia : Tokuda Hospital
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Varna : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Canada
Brampton : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Edmonton : (804) University of Alberta Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Moncton : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Montreal : (808) McGill University
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Montreal : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Oshawa : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sudbury : GSK Investigational Site
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Toronto : (806) Sunnybrook Odette Cancer Centre
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Toronto : (801) Princess Margaret Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Toronto : The Hospital for Sick Children
Effects of HQK-1001 in Patients With Sickle Cell Disease
Toronto : University Health Network Toronto General Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Chile
Santiago : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Temuco : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Vina del Mar : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
China
Beijing : Novartis Investigative Site Updated
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
Changsha : 15
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Fuzhou : 1
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Guangzhou : Department of Hematology, Liu Hua Qiao Hospital
Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Hangzhou : 6
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
View More »
Hangzhou : 5
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Jinan : 8
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Jinan : 7
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Shanxi : 13
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Shanxi : 14
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Tianjin : 2
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Wuxi : 4
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Xi'an : 9
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
Croatia
Zagreb : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Czech Republic
Benesov u Prahy : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Horovice : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kyjov : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Olomouc : (252) Fakultni nemocnice Olomouc, hemato-onkologicka klinika
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Ostrava-Poruba : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Praha : (253) Vseobecna Fakultni Nemocnice v Praze
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Praha : (254) Ustav Hematologie a Krevni Transfuze
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Praha 4 : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Praha 8 : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Denmark
Holbaek : Pharmacosmos
Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
Egypt
Cairo :
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
Cairo : Abu El Reesh Pediatric University Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Cairo : Ain Sham University Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Finland
Helsinki : Div. of Nephrologia, Helsenky, University Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Jakobstad : Pietarsaari Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Kajaaha : Kainuu Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
France
Aix en Provence : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Aix en Provence cedex 01 : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amiens : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Angers Cedex 9 : (307) Center Hospitalier Universitaire d' Angers
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Bayonne : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Besançon Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bobigny : (304) Hôpital Avicenne - Service d'Hématologie Clinique
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Bordeaux : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Boulogne sur Mer Cédex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bourg en Bresse : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brive la Gaillarde : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Colmar Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Creteil : Hôpital Henri Mondor
Safety Study of MP4CO in Adult Sickle Cell Patients
Créteil : Henri Mondor University Hospital
Rituximab in Auto-Immune Hemolytic Anemia
Dijon : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
La Seyne Sur Mer : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
La Tronche : (303) Hopital A. Michallon
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Le Mans Cedex 9 : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Lille :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Lille Cedex : (305) Hôpital Claude Hurlezk service des maladies du sang
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Longjumeau cedex 1 : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Marseille : (306) Institut Paoli Calmettes Centre Regional de Lutte Contre le Cancer
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Marseille : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Mont de Marsan : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Nancy : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Périgueux cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Paris : Research Facility
Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease
Paris Cedex 14 : (302) Groupe hospitalier Cochin Saint-Vincent de Paul
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Paris Cedex 20 : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Pontoise Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Pringy Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Reims : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Reims Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Rennes : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Rouen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Saint Grégoire cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Saint Quentin : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Soissons :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Soissons Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Soyaux : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Strasbourg : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Suresnes :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Vichy cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Villefranche Sur Saone Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Villejuif Cedex : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Germany
Alsfeld :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Alzey :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Augsburg : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bad Berka : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bad Nauheim :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
View More »
Bad Wildungen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bamberg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bayreuth :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Berlin : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Berlin :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
Berlin : Vivantes Klinikum Neukölln, Klinikum für Geburtsmedizin
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Berlin : Charité Universitätsmedizin Berlin
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Berlin :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bremerhaven : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Darmstadt :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Dresden : (359) Gemeinschaftspraxis fur Hamatologie un Onkologie
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Dresden : Univesitätsklinikum Carl Gustav Carus
Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients on Oral Antidiabetic Medication
Dresden : Acceleron Investigative Site
Study of ACE-536 for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)
Duisburg : (352) Sankt Johannes Hospital Duisburg
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Düsseldorf : (356) Universitätsklinikum Düsseldorf, Klinik für Hämatologie, Onkologie und Klinische Immunologie
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Erlangen : Research Facility
Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease
Essen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Freiburg : iOMEDICO
Clinical Registry on Anemia-Therapy (TAn-Registry)
Goslar : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gutersloh :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hagenow :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Halle/ Saale : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Halle/Saale : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Hamburg :
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
Hamm :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hannover : (354) Medizinische Hochschutle Hannover
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Hannover :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
Heidelberg : (357) Universitat Heidelberg
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Hemer : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Herne :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Herzberg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Homberg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hurth-Hermulheim :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Köln : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Köln : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Kaiserslautern :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Kassel : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Kiel :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
Koln :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Köln :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
Leverkusen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Ludwigslust :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Luebeck :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
München : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Magdeburg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Mannheim : (353) Universitatsklinikum Mannheim
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Mannheim : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Marburg : Klinik Für Frauenheilkunde und Geburtshilfe Universitätsklinikum Marburg
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Mayen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Mettmann :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Muenster : University Hospital Muenster
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Munchen : (355) Klinikum rechts der Isar, Technische Universitat Munchen
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Munchen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
München :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
München : Perinatalzentrum, Klinikum Innenstadt LMU
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Neunkirchen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Potsdam :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Quedlinburg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Saarlouis :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
Saarlouis :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Solingen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Stralsund : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ulm : University Hospital Ulm
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Ulm : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Viersen : Dr. med. Sven Herrnberger
MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
Würselen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Weisbaden :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Wuppertal :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
Greece
Athens : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Chania : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Larissa : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Marousi : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Piraeus : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Thessaloniki : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Thessaloniki : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Hong Kong
Hong Kong : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Hong Kong :
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Kowloon : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
New Territories : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
India
Ahmedabad :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Ahmedabad :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
Ahmednagar : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Aurangabad : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Bhubaneswar :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
View More »
Delhi :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Hyderabad :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Hyderabad :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
Hyderabad : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Jaipur : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kochi : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kolkata :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Kolkata :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
Kolkata : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lucknow : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mangalore : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Miraj : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mumbai :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Mumbai :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
Mumbai : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Nashik : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
New Delhi : Apollo Hospitals
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
New Delhi :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
New Delhi :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
New Delhi : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pune :
A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy
Pune :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
Pune : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Vadodara :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
Vellore :
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
Ireland
Galway :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Israel
Jerusalem : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Jerusalem : Hadassah Medical Organization
Safety and Efficacy of Sustained Erythropoietin Therapy
Kfar Saba : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Petach Tikva : (404) Rabin Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Poria Eylit : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Rehovot : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tel Aviv : (401) Tel Aviv Sourasky Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Tel Aviv : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tel Aviv : Tel Aviv Sourasky Medical Center
Safety and Efficacy of Sustained Erythropoietin Therapy
Tel Hashomer : (402) Chaim Sheba Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Italy
Alessandria : (456) Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Allessandria
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Ancona : U.O. Nefrologia e Dialisi, Azienda Ospeadaliero-Universitaria Ospedali Riuniti
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Anzio : Ospedali Riuniti Anzio-Nettuno, Nefrologia e dialisi ASL RMH
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bologna : (460) Instituto Di Ematologia ED Oncologia Medica "LA Seragnoli" Policlinico S. Orsola Malpighi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Cagliari : (461) Ospedale R. Binaghi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
View More »
Cagliari : (457) Azienda Ospedaliero-Universitaria di Cagliari
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Catania : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Catania : Azienda ospedialiera per l'Emergenza Cannizzaro - Divisione di Nefrologia, Dialisi e Trapianto
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Cefalù PA : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Chieri : TO 5 - SC Nefrologia 3 Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Faenza RA : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Firenze : (462) Azienda Ospedalieo - Universitaria Careggi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Lecce : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lugo RA : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Meldola FC : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Messina : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Milano : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Milano : Ospadle Niguarda Ca Granda - U.O. Nefrologia e Dialisi e Terapi Medica del Trapianto Renale
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Naples : (458) AORN A. Cardarelli
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Naples : Dipartimento do Patologia Sistematica
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Napoli : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Napoli : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Napoli : Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli - U.O. S.C. Nefrologia ed Emodialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Napoli : Dialysis
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Nocera : ASL SA 1 P.O. Umberto 1 - U.O.C. di Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Nola : Ospedale Santa maria Della Pieta U.O.C. di Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Padova : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Pavia : Lavoro e Delia Riabilitazione, Divisione Nefrologia ed Emodialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Ravenna : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Rionero in Vulture : (455) IRCCS Centro di Riferimento Oncologico di Basilicata di Rionero in Vulture
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Roma : (452) Azienda Ospedaliera Universitaria Policlinico Tor Vergata
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Roma : (463) Universita Cattolica Sacro Cuore
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Roma : (453) Azienda Policlinico Umberto l di Roma
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Roma : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Roma : Fondazinoe PTV Ploiclinico Tor Vergata U.O.S.D. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
S. Angelo dei Lombardi : Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
San Giovanni Rotondo FG : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Santa Maria : Presidio Ospedaliero S. Guiseppe e Melorio ausl CE/2 S-U.O. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Soverato : Presidio Ospedaliero de Soverato Servizio Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Torino : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Torino : Complessa Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Torino : OSPEDALE MARTINI - SC, Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Udine : (451) Azienda Ospedaliero Universitaria "S. Maria della Misericordia" di Udine
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Zingonia-Oslo Sotto : Bergamaschi, U.O. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Jamaica
Mona, Kingston 7 : University of the West Indies
Effects of HQK-1001 in Patients With Sickle Cell Disease
Japan
Fukuoka : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Hiroshima : (908) Hiroshima University Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Hiroshima : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Hyogo : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Isehara : (904) Tokai University School of Medicine
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
View More »
Ishikawa : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Kamogawa : (910) Kameda General Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Kumamoto : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Kyoto : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Nagasaki : (909) Nagasaki University Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Nagasaki : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Nagoya : (906) National Hospital Organization Nagoya Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Nagoya : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Osaka : (907) Osaka Red Cross Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Osaka : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Sapporo : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Sendai : (911) Tohoku University Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Shibuya : (902) Japanese Red Cross Medical Center
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Shimotsuga-gun : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Shimotsuke : (901) Jichi Medical University Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Shinagawa : (903) Kanto Medical Center NTT EC
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Tochigi : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Tokyo : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Toyama : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Korea, Republic of
Daegu : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Gwangju : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Seongnam-si, Gyeonggi-do : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Seoul : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lebanon
Beirut : American University of Beirut Medical Center
Effects of HQK-1001 in Patients With Sickle Cell Disease
Beirut : Rafik Hariri University Hospital
Effects of HQK-1001 in Patients With Sickle Cell Disease
Beirut : Chronic Care Center
Effects of HQK-1001 in Patients With Sickle Cell Disease
Lithuania
Vilnius : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Luxembourg
Differdange : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Luxembourg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Malaysia
Kota Bharu : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kota Kinabalu : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kuala Lumpur : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kuantan : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mexico
Aguascalientes :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Aguascalientes : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Colima : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Distrito Federal :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Guadalajara : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Merida : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mexicali :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Mexico : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Mexico : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Mexico City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Morelia :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Oaxaca : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Puebla : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pureto Vallarta :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Queretaro : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Veracruz :
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis
Montenegro
Podgorica :
An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)
Netherlands
Amstelveen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Breda : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Dordrecht : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Enschede : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Leiderdorp : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Purmerend : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Roosendaal : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Rotterdam : Erasmus Medical Center
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Rotterdam : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Vlissingen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Zutphen : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Philippines
Baguio City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Cebu City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Davao City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Makati City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Manila : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Metro Manila : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pasig City, MetroManila : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Quezon City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Taguig City : FNRI
Nutrient Fortified Oat Drink
Poland
Bartoszyce :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Bialystok : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bydgoszcz :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Bydgoszcz : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Ciechanow :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
View More »
Czestochowa :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Debica :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Gdansk :
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
Gdansk : (504) Katedra I Klinika Hematologii z Osrodkiem Transplantacji Szpiku Kostnego AM; SPSK nr 1
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Gdansk : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gdansk : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Gliwice :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Glucholazy : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Gorzow Wielkopolski :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Grudziadz :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Hajnowka :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Kepno :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Konin :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Koszalin : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Krakow : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Krakow : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Krakow : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Lodz :
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
Lodz :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Lodz : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Lubin : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Lublin :
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
Milicz :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Olsztyn : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Olsztyn : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Pila :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Polanica Zdroj :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Poznan : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Radom :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Rybnik :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Rzeszow :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Sandomierz :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Siedlce :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Slupsk :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Starachowice :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Suwalki :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Suwalki : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Szczecin : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Walbrzych : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Warsaw : (503) Instytut Hematologii i Tansfuzjologii, Klinika Hematologii
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Warszawa :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Warszawa : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Warszawa : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Wolomin :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Wroclaw :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Wroclaw : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Wroclaw : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Wroclaw : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Zgorzelec :
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
Portugal
Canelas : Caledial
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Coimbra : (553) Hospitais da Universidade de Coimbra
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Lisboa : (552) Instituto Português de Oncologia de Lisboa de Francisco Gentil, EPE
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Puerto Rico
Caguas : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Ponce : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Rio Piedras : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
San Juan : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
San Juan : Research Site
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Romania
Alba Iulia : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Baia-Mare : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brasov : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brasov : Spitalul Judetean
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Bucharest : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Bucuresti : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Cluj Napoca : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Cluj-Napoca : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Cluj-Napoca : Institutul Oncologic
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Craiova : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Craiova : Spitalul Municipal
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Lasi : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Oradea : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ramnicu Valcea : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Suceava : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Targu Mures : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Timisoara : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Timisoara : Research Site
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Timisoara : Oncomed
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma
Timisoara :
Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia
Russian Federation
Arkhangelsk : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Ivanovo : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kirov : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Krasnodar : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Moscow : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Moscow :
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Moscow : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Novosibirsk : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Obninsk : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Orenburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Penza : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Saint Petersburg : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Saratov : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
St Petersburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Stavropol' : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Ufa : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Voronezh : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Yaroslavl : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Serbia
Belgrade : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Gornji Matejevac : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kragujevac : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sremska Kamenica : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Singapore
Singapore : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Slovakia
Banska Bystrica : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Bratislava : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Kosice : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Slovenia
Golnik : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Pohorje : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
South Africa
Bloemfontein : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Johannesburg : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Overport : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Polokwane : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Spain
Alicante : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Alicante : Universitario de Alicante
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Barcelona : (607) Hospital Clinic i Provincial - Servicio de Hematologia y Hemoterapia
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Barcelona : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Barcelona : Hospital de Barcelona
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
View More »
Barcelona : Fundacio Puigvert
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Benalmadena : Xanit Hospital Internacional
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Benidorm : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Fuenlabrada : Fuenlabrada
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Granada : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Las Palmas de Gran Canaria : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Madrid : (606) Hospital Universitario La Paz
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Malaga : (603) Hospital Clinico Universitario Virgen de la Victoria
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Palma de Mallorca : (602) Hospital Son Llatzer
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Pontevedra : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Salamanca : (605) Hospital Universitario de Salamanca, Hospital Clinico, Sevicio de Hematologia
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Salamanca : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Sevilla : (608) Hospital Universitario Virgen del Rocio
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Terrassa : Hospital Mutua de Terrassa
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Valencia : (601) Hospital La Fe, Servicio de Hematologia
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Valencia : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Valencia : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Xativa : Hospital Lluis Alcanyis
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Sweden
Falun : Kvinnokliniken, Falu lasarett
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Linkoping : Linkopings Universitetssjukhus
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Lund : Kvinnokliniken, University Hospital
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Stockholm : Karolinska Universitetssjukhuset Huddinge, Centrum för fostermedicin KK
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Stockholm : Kvinnokliniken, Karolinska University Hospital
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
View More »
Stockholm : Karolinska University Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Uppsala : University Hospital, Dept of obstetrics and gynecology Uppsala
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Switzerland
Aarau : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Basel : Universitätsspital Basel, Geburtshilfe und Schwangerschaftsmedizin Frauenklinik
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Bern : Humboldtstrasse
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Bern : Inselspital, Department of Obstetrics and Gynecology
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Genève : HUG, Département de Gynécologie-Obstétrique
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
View More »
Lausanne : CHUV, Département de Gynécologie-Obstétrique
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Lugano : OR Lugano, sede Ospedale Civico, Clinica ginecologia ostetricia
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Zurich : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Zurich : Universitätsspital Zürich
Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
Zürich : Universitätsspital Zürich, Departement Frauenheilkunde
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Taiwan
Changhua : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kaohsiung : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Taichung : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Taichung City : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Tainan : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Thailand
Bangkok :
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
Turkey
Adana : Cukurova University Hospital
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Adana : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Ankara : (654) Gazi Universitesi Tip Fakultesi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Ankara : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Istanbul : (652) Istanbul Universitesi Istanbul Tip Fakultesi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
View More »
Istanbul : Istanbul Uni. Ist. Med. Faculty
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Istanbul : Zeynep Kamil Hospital, Arakiyeci Haci Mehmet Mahallesi.
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Istanbul : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Izmir : (653) Dokuz Eylul Universitesi Tip Fakultesi
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Izmir : Novartis Investigative Site
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Ukraine
Chernivtsi : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Dnipropetrovsk : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kirovograd : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Kyiv : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Lutsk : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
View More »
Lviv : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Sumy : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Uzhgorod : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
United Kingdom
Birmingham : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Bournemouth : (707) Royal Bournemouth Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Cardiff : (706) University Hospital of Wales
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Cardiff : Cardiff University
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Derby : Research Facility
Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease
View More »
Dorechester : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Dorset : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Leeds : (704) Saint James' University Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Leeds : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Liverpool : Research Site
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
London : (702) King's College Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
London :
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
London : Research Facility
Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease
London :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
London : King's College London
Safety Study of MP4CO in Adult Sickle Cell Patients
London : Guy's Hospital
Safety Study of MP4CO in Adult Sickle Cell Patients
London : Research Site Updated
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Manchester : (701) Christie Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Oxford : (705) John Radcliffe Hospital
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Worthing : Worthing Hospital
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
Worthing : Worthing Hospital
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
